JAK2V617F mutation for the early diagnosis of Ph- myeloproliferative neoplasms in patients with venous thromboembolism: a meta-analysis

Low prevalence of the JAK2V617F in patients with ischemic stroke or cerebral venous thrombosis

(2009) Sandra Guerra Xavier et al.   BLOOD COAGULATION & FIBRINOLYSIS

Occurrence of the JAK2 V617F mutation in the Budd–Chiari syndrome

(2009) Donatella Colaizzo et al.   BLOOD COAGULATION & FIBRINOLYSIS

Janus kinase-2 mutation, cirrhosis and splanchnic vein thrombosis

(2009) Donatella Colaizzo et al.   EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

JAK2V617F Mutation Screening as Part of the Hypercoagulable Work-up in the Absence of Splanchnic Venous Thrombosis or Overt Myeloproliferative Neoplasm: Assessment of Value in a Series of 664 Consecutive Patients

(2009) Animesh Pardanani et al.   MAYO CLINIC PROCEEDINGS

ClinicalJAK2V617F mutation testing: Limited utility for general hospital patients with venous and arterial thromboses in common locations

(2008) Gregory A. Abel et al.   AMERICAN JOURNAL OF HEMATOLOGY

MPL and JAK2 exon 12 mutations in patients with the Budd-Chiari syndrome or extrahepatic portal vein obstruction

(2008) G. M. Bergamaschi et al.   BLOOD

The impact of JAK2 and MPL mutations on diagnosis and prognosis of splanchnic vein thrombosis: a report on 241 cases

(2008) J.-J. Kiladjian et al.   BLOOD

TheJAK2V617Fmutation and thrombosis

(2008) S. K. Austin et al.   BRITISH JOURNAL OF HAEMATOLOGY

Undiagnosed Myeloproliferative Disease in Cases of Intra-Abdominal Thrombosis: The Utility of the JAK2 617F Mutation

(2008) Stephanie P’ng et al.   Clinical Gastroenterology and Hepatology

Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: incidence, risk factors, and effect of treatments

(2008) V. De Stefano et al.   HAEMATOLOGICA

Molecular and chromosomal alterations: new therapies for relapsed acute myeloid leukemia

(2008) Michela Palmisano et al.   Hematology

JAK2 V617F mutation is not involved in thromboembolism in IBD

(2008) Ouafae Karimi et al.   INFLAMMATORY BOWEL DISEASES

JAK2V617F mutation is not associated with unexplained recurrent arterial and venous thrombosis

(2008) Damien Sène et al.   THROMBOSIS RESEARCH

TheJAK2V617Ftyrosine kinase mutation identifies clinically latent myeloproliferative disorders in patients presenting with hepatic or portal vein thrombosis

(2007) C. GOULDING et al.   International Journal of Laboratory Hematology